(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of -2.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Wave Life Sciences's revenue in 2025 is $108,302,000.On average, 8 Wall Street analysts forecast WVE's revenue for 2025 to be $10,201,601,872, with the lowest WVE revenue forecast at $5,372,010,735, and the highest WVE revenue forecast at $15,340,927,799. On average, 7 Wall Street analysts forecast WVE's revenue for 2026 to be $11,827,325,806, with the lowest WVE revenue forecast at $3,599,247,192, and the highest WVE revenue forecast at $20,272,433,654.
In 2027, WVE is forecast to generate $15,930,314,120 in revenue, with the lowest revenue forecast at $5,065,038,693 and the highest revenue forecast at $32,953,448,709.